Differential Effects of Two Chronic Diazepam Treatment Regimes on Withdrawal Anxiety and AMPA Receptor Characteristics
The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Withdrawal from chronic benzodiazepines is associated with increased anxiety and seizure susceptibility. Neuroadaptive changes in neural activity occur in limbo-cortical structures although changes at the level of the GABA(A) receptor do not provide an adequate explanation for these functional changes. We have employed two diazepam treatment regimes known to produce differing effects on withdrawal aversion in the rat and examined whether withdrawal-induced anxiety was accompanied by changes in AMPA receptor characteristics. Rats were given 28 days treatment with diazepam by the intraperitoneal (i.p.) route (5 mg/kg) and the subcutaneous (s.c.) route (15 mg/kg). Withdrawal anxiety in the elevated plus maze was evident in the group withdrawn from chronic s.c. diazepam (relatively more stable plasma levels) but not from the chronic i.p. group (fluctuating daily plasma levels). In the brains of these rats, withdrawal anxiety was accompanied by increased [3H]Ro48 8587 binding in the hippocampus and thalamus, and decreased GluR1 and GluR2 subunit mRNA expression in the amygdala (GluR1 and GluR2) and cortex (GluR1). The pattern of changes was different in the chronic i.p. group where in contrast to the chronic s.c. group, there was reduced [3H]Ro48 8587 binding in the hippocampus and no alterations in GluR1 and GluR2 subunit expression in the amygdala. While both groups showed reduced GluR1 mRNA subunit expression in the cortex overall, only the agranular insular cortex exhibited marked reductions following chronic i.p. diazepam. Striatal GluR2 mRNA expression was increased in the i.p. group but not the s.c. group. Taken together, these data are consistent with differential neuroadaptive processes in AMPA receptor plasticity being important in withdrawal from chronic benzodiazepines. Moreover, these processes may differ both at a regional and receptor function level according to the behavioral manifestations of withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, significant reductions of mGLuR1 (cortex and amygdala) and mGluR2 mRNA (amygdala) were reported in rats treated chronically with diazepam, even though the effects were complex and dependent on treatment route (subcutaneous or intraperitoneal injections).”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [130]
In the citing paper
“changes in AMPA receptor subunits have been reported to be altered after long-term benzodiazepine exposure [130].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [130]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822 · cited 1×
“The EPM test used in these studies to assess the anxiety state of the animals was that used by Allison et al (2002) and was based on that used by Handley and Mithani (1984) and Pellow et al (1985).”
MethodGray, J. A. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00013066 · Cited by 4,477
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
The role of the amygdala in fear and anxiety
Davis, M. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.002033 · Cited by 2,357 · cited 1×
“Stimulation of the amygdala in animals provokes fear behaviors and defensive reactions (see Davis, 1992a, b, 1994 for reviews) and amygdaloid lesions reduce the expression of signs of fear and anxiety (Treit et al, 1993).”
BackgroundThe Neuropsychology of Anxiety: An enquiry into the function of the septo-hippocampal system
Gray, J. A., & McNaughton, N. (2003) · doi:10.1093/acprof:oso/9780198522713.001.0001 · Cited by 1,928
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction.
Aggleton, J. P. (1992) · Wiley-Liss eBooks · Cited by 1,536
A Family of AMPA-Selective Glutamate Receptors
Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990) · Science · doi:10.1126/science.2166337 · Cited by 1,479 · cited 3×
“Oligonucleotide probes (45-mers) complimentary to specific regions within the sequences of mRNA of GluR1 and GluR2 AMPA receptor subunits were employed (Keinanen et al, 1990).”
BackgroundMethodResultHandley, S. L., & Mithani, S. (1984) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00504983 · Cited by 969 · cited 1×
“The EPM test used in these studies to assess the anxiety state of the animals was that used by Allison et al (2002) and was based on that used by Handley and Mithani (1984) and Pellow et al (1985).”
MethodMolecular Cloning and Functional Expression of Glutamate Receptor Subunit Genes
Boulter, J., Hollmann, M., O'Shea-Greenfield, A., Hartley, M., Deneris, E., Maron, C., & Heinemann, S. (1990) · Science · doi:10.1126/science.2168579 · Cited by 938 · cited 1×
“The GluR2 subunit confers Ca2þ impermeability on the AMPA receptor (Boulter et al, 1990; Pellegrini-Giampietro et al, 1997).”
BackgroundEthopharmacological analysis of rat behavior on the elevated plus-maze
Cruz, A. P. M., Frei, F., & Graeff, F. G. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90472-3 · Cited by 823 · cited 2×
“The measurement of the total number of arm entries during the test period also gives a measure of the general locomotor activity of the subject and allows this measure to be ruled out as a factor in the test (Cruz et al, 1994; Fernandes and File, 1996; Rex et al, 1996).”
BackgroundCharacterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., & Huganir, R. L. (1996) · Neuron · doi:10.1016/s0896-6273(00)80144-0 · Cited by 812 · cited 1×
“The GluR1 receptor subunit has phosphorylation sites, which when activated increase current flow through the receptor (Keinanen et al, 1990; Roche et al, 1996; Banke et al, 2000).”
BackgroundRodgers, R. J., & Johnson, N. J. T. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00138-m · Cited by 791 · cited 2×
“…behaviors in the EPM such as head dipping, SAPs, rearing, and end exploration (‘risk assessment’ behaviors; Cruz et al, 1994; Shepherd et al, 1994; Dawson and Tricklebank, 1995; Rodgers and Johnson, 1995) also revealed behaviors consistent with increased anxiety in the s.c. DZP-withdrawn group.”
BackgroundNeurotransmission in the rat amygdala related to fear and anxiety
Davis, M., Rainnie, D., & Cassell, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90106-6 · Cited by 771
Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J., & Dourish, C. T. (1994) · Psychopharmacology · doi:10.1007/bf02244871 · Cited by 739 · cited 1×
“…of ethological behaviors in the EPM such as head dipping, SAPs, rearing, and end exploration (‘risk assessment’ behaviors; Cruz et al, 1994; Shepherd et al, 1994; Dawson and Tricklebank, 1995; Rodgers and Johnson, 1995) also revealed behaviors consistent with increased anxiety in the…”
BackgroundControl of GluR1 AMPA receptor function by cAMP-dependent protein kinase
Banke, T. G., Bowie, D., Lee, H.-K., Huganir, R. L., Schousboe, A., & Traynelis, S. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00089.2000 · Cited by 652 · cited 1×
“The GluR1 receptor subunit has phosphorylation sites, which when activated increase current flow through the receptor (Keinanen et al, 1990; Roche et al, 1996; Banke et al, 2000).”
Background(1992) · Cited by 626
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560 · cited 1×
“This is characterized by tolerance to their sedative, muscle relaxant, and anticonvulsant effects and a characteristic withdrawal syndrome on cessation of treatment (Nutt, 1986; Woods et al, 1992, 1995).”
BackgroundUse of the elevated plus maze in the search for novel anxiolytic agents
Dawson, G. R., & Tricklebank, M. D. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88973-7 · Cited by 559 · cited 4×
“…behaviors in the EPM such as head dipping, SAPs, rearing, and end exploration (‘risk assessment’ behaviors; Cruz et al, 1994; Shepherd et al, 1994; Dawson and Tricklebank, 1995; Rodgers and Johnson, 1995) also revealed behaviors consistent with increased anxiety in the s.c. DZP-withdrawn group.”
BackgroundInfluentialThe GluR2 (GluR-B) hypothesis: Ca2+-permeable AMPA receptors in neurological disorders
Pellegrini-Giampietro, D. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01100-4 · Cited by 548 · cited 1×
“The GluR2 subunit confers Ca2þ impermeability on the AMPA receptor (Boulter et al, 1990; Pellegrini-Giampietro et al, 1997).”
BackgroundBeck, C., & Fibiger, H. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00709.1995 · Cited by 547 · cited 1×
“…or level of anxiety in the animals since these regions have been shown to be involved in various memory and emotional functions and to be activated by a range of anxiogenic stimuli (Beck and Fibiger, 1995; Yokoyama and Sasaki, 1999; Bruijnzeel et al, 1999; Del Cano et al, 2000; Shibata, 2000).”
BackgroundWenthold, R. J., Yokotani, N., Doi, K., & Wada, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48523-7 · Cited by 521 · cited 1×
“The particular subunit composition of native AMPA receptors can have profound consequences for receptor function (Wenthold et al, 1992), which then has further consequences for synaptic function and plasticity.”
BackgroundThe Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction
Eslinger, P. J. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90106-i · Cited by 491
Leonard, A. S., Davare, M. A., Horne, M. C., Garner, C. C., & Hell, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19518 · Cited by 421
Mody, I., & Heinemann, U. (1987) · Nature · doi:10.1038/326701a0 · Cited by 395 · cited 1×
“The hippocampal formation has been implicated in anxiety (Gray, 1987; Pratt, 1992; Pratt et al, 1988), kindling, and epileptogenic behavior (eg Mody and Heinemann, 1987; Gale, 1992).”
Albin, R. L., Makowiec, R. L., Hollingsworth, Z. R., Dure, L. S., Penney, J. B., & Young, A. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90006-n · Cited by 367 · cited 1×
“This pattern of binding is also consistent with that found when employing other AMPA receptor radioligands such as [3H]AMPA (Monaghan et al, 1984; Rainbow et al, 1984; Olsen et al, 1987; Nielsen et al, 1988; Albin et al, 1992) and [3H]CNQX (Nielsen et al, 1990).”
ResultBÜTTNER‐ENNEVER, J. (1997) · Journal of Anatomy · doi:10.1046/j.1469-7580.1997.191203153.x · Cited by 359
The influence of open arm ledges and maze experience in the elevated plus-maze
Fernandes, C., & File, S. E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02171-x · Cited by 311 · cited 1×
“The measurement of the total number of arm entries during the test period also gives a measure of the general locomotor activity of the subject and allows this measure to be ruled out as a factor in the test (Cruz et al, 1994; Fernandes and File, 1996; Rex et al, 1996).”
BackgroundSubcortical Structures and Pathways Involved in Convulsive Seizure Generation
Gale, K. (1992) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199204010-00007 · Cited by 303 · cited 1×
“The hippocampal formation has been implicated in anxiety (Gray, 1987; Pratt, 1992; Pratt et al, 1988), kindling, and epileptogenic behavior (eg Mody and Heinemann, 1987; Gale, 1992).”
Pellegrini-Giampietro, D. E., Bennett, M. V., & Zukin, R. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4157 · Cited by 249 · cited 1×
“The patterns of GluR1 and GluR2 mRNA expression were found to be heterogeneous in rat brain and comparable to that found in previous studies (Keinanen et al, 1990; Pellegrini-Giampietro et al, 1991).”
ResultHodges, H., Green, S., & Glenn, B. (1987) · Psychopharmacology · doi:10.1007/bf00176484 · Cited by 242 · cited 8×
“This relationship might account for the potent anxiolytic effects of drugs that facilitate GABA (eg BZs) and also suggests that modulation of AMPA receptors may have a similar anxiolytic effect.”
BackgroundInfluentialDistribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography
Monaghan, D. T., Yao, D., & Cotman, C. W. (1984) · Brain Research · doi:10.1016/0006-8993(84)90636-x · Cited by 228 · cited 2×
“This is consistent with previous ISH studies and also with studies examining [3H]AMPA binding (Monaghan et al, 1984; Rainbow et al, 1984; Olsen et al, 1987; Nielsen et al, 1988) and [3H]Ro48 8587 binding (Mutel et al, 1998) to the AMPA receptor in rat brain.”
Tolerance to the behavioral actions of benzodiazepines
File, S. E. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90037-5 · Cited by 205 · cited 2×
“…our laboratory using the same i.p. DZP treatment protocol that produces tolerance to locomotor depressant and anticonvulsant effects and to regionally selective alterations in local cerebral glucose utilization (File, 1985; Gonsalves and Gallager, 1987; Laurie and Pratt, 1989; Pratt et al, 1998).”
BackgroundAnticonflict effect of the benzodiazepines mediated by a gabaergic mechanism in the amygdala
Scheel-Krüger, J., & Petersen, E. N. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90564-7 · Cited by 170
Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence
Allison, C., & Pratt, J. A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00029-9 · Cited by 160 · cited 2×
“Glutamate is a key candidate for changes in excitatory transmission mechanisms and BZ dependence (Stephens, 1995; Allison and Pratt, 2003): firstly, since there are defined neuroanatomical relationships between glutamatergic and GABAergic neurons in the CNS and, secondly, because of the pivotal role of glutamatergic n…”
BackgroundSelf-citationAMPA receptor-mediated regulation of a Gi-protein in cortical neurons
Wang, Y., Small, D. L., Stanimirovic, D. B., Morley, P., & Durkin, J. P. (1997) · Nature · doi:10.1038/39062 · Cited by 154 · cited 1×
“The GluR1 subunit has also been shown to interact with an inhibitory G protein in cortical neurons (Wang et al, 1997), thus indicating a metabotropic function of the AMPA receptor.”
BackgroundTreit, D., Pesold, C., & Rotzinger, S. (1993) · Behavioral Neuroscience · doi:10.1037//0735-7044.107.5.770 · Cited by 137 · cited 1×
“Stimulation of the amygdala in animals provokes fear behaviors and defensive reactions (see Davis, 1992a, b, 1994 for reviews) and amygdaloid lesions reduce the expression of signs of fear and anxiety (Treit et al, 1993).”
BackgroundStrain differences in fear-motivated behavior of rats
Rex, A., Sondern, U., Voigt, J., Franck, S., & Fink, H. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02128-0 · Cited by 135 · cited 1×
“The measurement of the total number of arm entries during the test period also gives a measure of the general locomotor activity of the subject and allows this measure to be ruled out as a factor in the test (Cruz et al, 1994; Fernandes and File, 1996; Rex et al, 1996).”
BackgroundQuantitative autoradiography of binding sites for [3H]AMPA, a structural analogue of glutamic acid
Rainbow, T. C., Wieczorek, C. M., & Halpain, S. (1984) · Brain Research · doi:10.1016/0006-8993(84)91025-4 · Cited by 134 · cited 2×
“This is consistent with previous ISH studies and also with studies examining [3H]AMPA binding (Monaghan et al, 1984; Rainbow et al, 1984; Olsen et al, 1987; Nielsen et al, 1988) and [3H]Ro48 8587 binding (Mutel et al, 1998) to the AMPA receptor in rat brain.”
Result[3H]AMPA binding to glutamate receptor subpopulations in rat brain
Olsen, R. W., Szamraj, O., & Houser, C. R. (1987) · Brain Research · doi:10.1016/0006-8993(87)90030-8 · Cited by 133 · cited 2×
“This is consistent with previous ISH studies and also with studies examining [3H]AMPA binding (Monaghan et al, 1984; Rainbow et al, 1984; Olsen et al, 1987; Nielsen et al, 1988) and [3H]Ro48 8587 binding (Mutel et al, 1998) to the AMPA receptor in rat brain.”
ResultImpagnatiello, F., Pesold, C., Longone, P., Caruncho, H., Fritschy, J. M., Costa, E., & Guidotti, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09071-6 · Cited by 124 · cited 2×
“…Publishing Group All rights reserved 0893-133X/06 $30.00 www.neuropsychopharmacology.org O’Donovan et al, 1992a, b; Tietz et al, 1993; Zhao et al, 1994; Impagnatiello et al, 1996; Holt et al, 1996, 1999; Pratt et al, 1998; Arnot et al, 2001), although this may be due to both methodological and…”
BackgroundInfluentialThe neuroanatomical basis of anxiety
Pratt, J. A. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90014-q · Cited by 122 · cited 1×
“The hippocampal formation has been implicated in anxiety (Gray, 1987; Pratt, 1992; Pratt et al, 1988), kindling, and epileptogenic behavior (eg Mody and Heinemann, 1987; Gale, 1992).”
Self-citationAnxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens
McCullough, L. D., & Salamone, J. D. (1992) · Psychopharmacology · doi:10.1007/bf02245888 · Cited by 119 · cited 1×
“Furthermore, anxiogenic drugs such as inverse BZ agonists increase nucleus accumbens dopamine activity (McCullough and Salamone, 1992).”
BackgroundEffects of continuous diazepam administration on GABAA subunit mRNA in rat brain
Heninger, C., Saito, N., Tallman, J. F., Garrett, K. M., Vitek, M. P., Duman, R. S., & Gallager, D. W. (1990) · Journal of Molecular Neuroscience · doi:10.1007/bf02876917 · Cited by 118 · cited 1×
“…evidence for changes in these subunits as being responsible for the changes in neural activity demonstrated during BZ tolerance and withdrawal (Heninger et al, 1990; Kang and Miller, 1991; Online publication: 18 May 2005 at http://www.acnp.org/citations/ Npp051805040440/default.pdf Received…”
BackgroundDecreased GABAAreceptor subunit mRNA concentrations following chronic lorazepam administration
Kang, I., & Miller, L. G. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb09781.x · Cited by 117 · cited 1×
“…in these subunits as being responsible for the changes in neural activity demonstrated during BZ tolerance and withdrawal (Heninger et al, 1990; Kang and Miller, 1991; Online publication: 18 May 2005 at http://www.acnp.org/citations/ Npp051805040440/default.pdf Received 13 October 2004;…”
BackgroundHolt, R. A., Bateson, A. N., & Martin, I. L. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00064-0 · Cited by 111 · cited 2×
“However, there is conflicting evidence for changes in these subunits as being responsible for the changes in neural activity demonstrated during BZ tolerance and withdrawal (Heninger et al, 1990; Kang and Miller, 1991; Online publication: 18 May 2005 at http://www.acnp.org/citations/ Npp051805040440/default.pdf Receiv…”
BackgroundInfluentialCostall, B., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11821.x · Cited by 110 · cited 1×
“Notably, local infusion of BZs in the basolateral and lateral nuclei of the amygdala produces anxiolytic effects in animal models of anxiety (ScheelKruger and Petersen, 1982; Costall et al, 1989).”
BackgroundThe pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma
Friedman, H. L., Abernethy, D. R., Greenblatt, D., & Shader, R. I. (1986) · Psychopharmacology · doi:10.1007/bf00180822 · Cited by 109 · cited 5×
“…either a single withdrawal event (s.c. treatment) or repeated withdrawal events (i.p. treatment), based on pharmacokinetic evidence in rats (Friedman et al, 1986; Fernandes et al, 1999; Allison et al, 2002) and behavioral evidence in mice that repeated withdrawal from DZP results in…”
BackgroundInfluentialNielsen, E. Ø., Drejer, J., Cha, J. J., Young, A. B., & Honoré, T. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01925.x · Cited by 103 · cited 1×
“This pattern of binding is also consistent with that found when employing other AMPA receptor radioligands such as [3H]AMPA (Monaghan et al, 1984; Rainbow et al, 1984; Olsen et al, 1987; Nielsen et al, 1988; Albin et al, 1992) and [3H]CNQX (Nielsen et al, 1990).”
ResultDiazepam dependence prevented by glutamate antagonists.
Steppuhn, K. G., & Turski, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6889 · Cited by 101 · cited 2×
“One group has suggested differential involvement of NMDA and AMPA receptors in DZP withdrawal, with AMPA receptor mechanisms being critical for initiating the withdrawal symptoms (Steppuhn and Turski, 1993), akin to their role in other forms of synaptic activity such as LTP.”
BackgroundSites of action of ondansetron to inhibit withdrawal from drugs of abuse
Costall, B., Jones, B., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90132-2 · Cited by 101 · cited 1×
“Interestingly, increased anxiety on withdrawal from BZs has often been difficult to detect in animal studies and may be influenced by a variety of factors (Baldwin and File, 1989; File, 1989; Costall et al, 1990; Wright et al, 1992).”
BackgroundIzzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628698 · Cited by 90 · cited 3×
“Furthermore, 96 h following a chronic escalating dose regime (5–20 mg/kg oral DZP three times per day), withdrawal anxiety and increases in hippocampal and cortical GluR1 subunit mRNA and protein occurred (Izzo et al, 2001).”
BackgroundMethodInfluentialBruijnzeel, A. W., Stam, R., Compaan, J. C., Croiset, G., Akkermans, L. M. A., Olivier, B., & Wiegant, V. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01350-x · Cited by 80 · cited 1×
“…or level of anxiety in the animals since these regions have been shown to be involved in various memory and emotional functions and to be activated by a range of anxiogenic stimuli (Beck and Fibiger, 1995; Yokoyama and Sasaki, 1999; Bruijnzeel et al, 1999; Del Cano et al, 2000; Shibata, 2000).”
BackgroundBenzodiazepine dependence in the clinic: reason for anxiety?
Nutt, D. J. (1986) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(86)90420-7 · Cited by 75 · cited 1×
“This is characterized by tolerance to their sedative, muscle relaxant, and anticonvulsant effects and a characteristic withdrawal syndrome on cessation of treatment (Nutt, 1986; Woods et al, 1992, 1995).”
BackgroundZhao, T. J., Chiu, T. H., & Rosenberg, H. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10150-8 · Cited by 72 · cited 2×
“…& 2006 Nature Publishing Group All rights reserved 0893-133X/06 $30.00 www.neuropsychopharmacology.org O’Donovan et al, 1992a, b; Tietz et al, 1993; Zhao et al, 1994; Impagnatiello et al, 1996; Holt et al, 1996, 1999; Pratt et al, 1998; Arnot et al, 2001), although this may be due to both…”
BackgroundInfluentialYokoyama, C., & Sasaki, K. (1999) · Brain Research · doi:10.1016/s0006-8993(98)00927-5 · Cited by 71 · cited 1×
“…or level of anxiety in the animals since these regions have been shown to be involved in various memory and emotional functions and to be activated by a range of anxiogenic stimuli (Beck and Fibiger, 1995; Yokoyama and Sasaki, 1999; Bruijnzeel et al, 1999; Del Cano et al, 2000; Shibata, 2000).”
BackgroundA glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands
Stephens, D. N. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00004 · Cited by 68 · cited 2×
“Glutamate is a key candidate for changes in excitatory transmission mechanisms and BZ dependence (Stephens, 1995; Allison and Pratt, 2003): firstly, since there are defined neuroanatomical relationships between glutamatergic and GABAergic neurons in the CNS and, secondly, because of the pivotal…”
BackgroundDizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats
File, S. E., & Fernandes, C. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90282-8 · Cited by 68 · cited 1×
“Several studies have also provided evidence for a role for NMDA receptor antagonists in blocking the behavioral components of BZ tolerance and withdrawal (Steppuhn and Turski, 1993; File and Fernandes, 1994; Koff et al, 1997; Tsuda et al, 1998a, b).”
BackgroundWright, I. K., Heaton, M., Upton, N., & Marsden, C. A. (1992) · Psychopharmacology · doi:10.1007/bf02245168 · Cited by 66 · cited 1×
“Interestingly, increased anxiety on withdrawal from BZs has often been difficult to detect in animal studies and may be influenced by a variety of factors (Baldwin and File, 1989; File, 1989; Costall et al, 1990; Wright et al, 1992).”
BackgroundO’Donovan, M. C., Buckland, P. R., Spurlock, G., & McGuffin, P. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90051-v · Cited by 66
Thiocyanate stabilizes AMPA binding to the quisqualate receptor
Nielsen, E. Ø., Cha, J.-H. J., Honoré, T., Penney, J. B., & Young, A. B. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90383-4 · Cited by 65 · cited 2×
“This is consistent with previous ISH studies and also with studies examining [3H]AMPA binding (Monaghan et al, 1984; Rainbow et al, 1984; Olsen et al, 1987; Nielsen et al, 1988) and [3H]Ro48 8587 binding (Mutel et al, 1998) to the AMPA receptor in rat brain.”
ResultGonsalves, S. F., & Gallager, D. W. (1987) · Brain Research · doi:10.1016/0006-8993(87)90993-0 · Cited by 65 · cited 2×
“…our laboratory using the same i.p. DZP treatment protocol that produces tolerance to locomotor depressant and anticonvulsant effects and to regionally selective alterations in local cerebral glucose utilization (File, 1985; Gonsalves and Gallager, 1987; Laurie and Pratt, 1989; Pratt et al, 1998).”
BackgroundFernandes, C., Arnot, M. I., Irvine, E. E., Bateson, A. N., Martin, I. L., & File, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130051056 · Cited by 64 · cited 3×
“…chronic s.c. DZP treatment regimen employed (15 mg/kg/day s.c. for 28 days) is based on studies by other groups in both rats (Fernandes et al, 1999; Arnot et al, 2001) and mice (Steppuhn et al, 1993; Ward and Stephens, 1998; Dunworth et al, 2000), with the intention of…”
BackgroundTietz, E. I., Huang, X., Weng, X., Rosenberg, H. C., & Chiu, T. H. (1993) · Journal of Molecular Neuroscience · doi:10.1007/bf02821559 · Cited by 57 · cited 1×
“…(2006) 31, 602–619 & 2006 Nature Publishing Group All rights reserved 0893-133X/06 $30.00 www.neuropsychopharmacology.org O’Donovan et al, 1992a, b; Tietz et al, 1993; Zhao et al, 1994; Impagnatiello et al, 1996; Holt et al, 1996, 1999; Pratt et al, 1998; Arnot et al, 2001), although this…”
BackgroundInfluentialRole of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats
Green, S., & Vale, A. L. (1992) · Behavioural Pharmacology · doi:10.1097/00008877-199206000-00010 · Cited by 53 · cited 8×
“This relationship might account for the potent anxiolytic effects of drugs that facilitate GABA (eg BZs) and also suggests that modulation of AMPA receptors may have a similar anxiolytic effect.”
BackgroundInfluentialSwedberg, M. D. B., Jacobsen, P., & Honoré, T. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10570-3 · Cited by 50 · cited 1×
“Indeed, local infusion of AMPA receptor antagonists into the amygdala produces an anxiolytic effect (Mesches et al, 1996) as does systemic administration (Swedberg et al, 1995; Kotlinska and Liljequist, 1998).”
BackgroundSickle, B. J. V., Xiang, K., & Tietz, E. I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300531 · Cited by 49 · cited 5×
“…evidence from studies in which large doses of BZs have been administered has provided further support for the involvement of alterations in AMPA receptor properties, particularly in the hippocampus, following BZ withdrawal (Izzo et al, 2001; Van Sickle and Tietz, 2002; Van Sickle et al, 2004).”
BackgroundInfluentialLong-term treatment with abecarnil does not induce diazepam-like dependence in mice.
Steppuhn, K. G., Schneider, H. H., Turski, L., & Stephens, D. N. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10157-2 · Cited by 48 · cited 1×
“…employed (15 mg/kg/day s.c. for 28 days) is based on studies by other groups in both rats (Fernandes et al, 1999; Arnot et al, 2001) and mice (Steppuhn et al, 1993; Ward and Stephens, 1998; Dunworth et al, 2000), with the intention of producing relatively more stable plasma levels of DZP…”
BackgroundMesches, M. H., Bianchin, M. M., & McGaugh, J. L. (1996) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.0073 · Cited by 48 · cited 1×
“Indeed, local infusion of AMPA receptor antagonists into the amygdala produces an anxiolytic effect (Mesches et al, 1996) as does systemic administration (Swedberg et al, 1995; Kotlinska and Liljequist, 1998).”
BackgroundBenzodiazepine Dependence: From Neural Circuits to Gene Expression
Pratt, J. A., Brett, R. R., & Laurie, D. J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00539-x · Cited by 47 · cited 3×
“…our laboratory using the same i.p. DZP treatment protocol that produces tolerance to locomotor depressant and anticonvulsant effects and to regionally selective alterations in local cerebral glucose utilization (File, 1985; Gonsalves and Gallager, 1987; Laurie and Pratt, 1989; Pratt et al, 1998).”
BackgroundSelf-citationCrépel, V., Khazipov, R., & Ben-Ari, Y. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.4.2071 · Cited by 47 · cited 1×
“There is a close inter-relationship between GABA and glutamate transmission in the hippocampus, such that if GABAergic inhibition is removed, glutamatergic polysynaptic responses mediated by AMPA and NMDA receptors are evoked (Crepel et al, 1997).”
BackgroundKotlinska, J. H., & Liljequist, S. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00565-0 · Cited by 45 · cited 1×
“Indeed, local infusion of AMPA receptor antagonists into the amygdala produces an anxiolytic effect (Mesches et al, 1996) as does systemic administration (Swedberg et al, 1995; Kotlinska and Liljequist, 1998).”
BackgroundComparison of Single‐ and Repeated‐Dose Pharmacokinetics of Diazepam
Walker, M. C., Tong, X., Brown, S., Shorvon, S. D., & Patsalos, P. N. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01374.x · Cited by 42 · cited 1×
“DZP when injected i.p. in the rat is rapidly absorbed and eliminated (plasma t1/2¼ 0.88 h, brain t1/2¼ 0.89 h; Friedman et al, 1986), with no evidence for repeated injection significantly prolonging the serum t1/2 of DZP compared to that after a single i.p. injection (Walker et al, 1998).”
BackgroundInfluentialOrganization of retrosplenial cortical projections to the laterodorsal thalamic nucleus in the rat
Shibata, H. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)00174-7 · Cited by 37 · cited 1×
“…or level of anxiety in the animals since these regions have been shown to be involved in various memory and emotional functions and to be activated by a range of anxiogenic stimuli (Beck and Fibiger, 1995; Yokoyama and Sasaki, 1999; Bruijnzeel et al, 1999; Del Cano et al, 2000; Shibata, 2000).”
BackgroundArnot, M. I., Davies, M., Martin, I. L., & Bateson, A. N. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1115 · Cited by 33 · cited 6×
“Nevertheless, the i.p. treatment is likely to have produced neuroadaptive changes reflecting dependence since tolerance develops to its locomotor depressant and anticonvulsant effects and to the regionally selective alterations in local cerebral glucose utilization (File, 1985; Gonsalves and Gallager, 1987; Laurie and…”
BackgroundResultInfluentialThe NMDA Receptor Competitive Antagonist CPP Modulates Benzodiazepine Tolerance and Discontinuation
Koff, J. M., Pritchard, G. A., Greenblatt, D. J., & Miller, L. G. (2008) · Pharmacology · doi:10.1159/000139531 · Cited by 33 · cited 1×
“Several studies have also provided evidence for a role for NMDA receptor antagonists in blocking the behavioral components of BZ tolerance and withdrawal (Steppuhn and Turski, 1993; File and Fernandes, 1994; Koff et al, 1997; Tsuda et al, 1998a, b).”
BackgroundTsuda, M., Shimizu, N., Yajima, Y., Suzuki, T., & Misawa, M. (1998) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005172 · Cited by 33 · cited 1×
“Several studies have also provided evidence for a role for NMDA receptor antagonists in blocking the behavioral components of BZ tolerance and withdrawal (Steppuhn and Turski, 1993; File and Fernandes, 1994; Koff et al, 1997; Tsuda et al, 1998a, b).”
BackgroundVan Sickle, B. J., Cox, A. S., Schak, K., John Greenfield, L., & Tietz, E. I. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00152-1 · Cited by 33 · cited 1×
“A reduction in NMDA receptor-mediated transmission in the CA1 region of the hippocampus coupled with reductions in NR2B subunit mRNA and protein expression have been reported following withdrawal from chronic flurazepam treatment (Van Sickle et al, 2002).”
BackgroundInfluentialWard, B. O., & Stephens, D. N. (1998) · Psychopharmacology · doi:10.1007/s002130050521 · Cited by 32 · cited 9×
“…(Allison et al, 2005) consistent with a hypothesis that neuroadaptive changes at the level of the AMPA receptor are involved in the differential effects of these treatment regimes on behavioral measures of with- drawal (Ward and Stephens, 1998; Dunworth and Stephens, 1998; Dunworth et al, 2000).”
BackgroundResultInfluentialBaldwin, H. A., & File, S. E. (1989) · Psychopharmacology · doi:10.1007/bf00439464 · Cited by 32 · cited 1×
“Interestingly, increased anxiety on withdrawal from BZs has often been difficult to detect in animal studies and may be influenced by a variety of factors (Baldwin and File, 1989; File, 1989; Costall et al, 1990; Wright et al, 1992).”
BackgroundDecreased GABA Enhancement of Benzodiazepine Binding After a Single Dose of Diazepam
Holt, R. A., Bateson, A. N., & Martin, I. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722219.x · Cited by 31 · cited 2×
“However, there is conflicting evidence for changes in these subunits as being responsible for the changes in neural activity demonstrated during BZ tolerance and withdrawal (Heninger et al, 1990; Kang and Miller, 1991; Online publication: 18 May 2005 at http://www.acnp.org/citations/ Npp051805040440/default.pdf Receiv…”
BackgroundInfluentialVan Sickle, B. J., & Tietz, E. I. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00065-5 · Cited by 29 · cited 5×
“…evidence from studies in which large doses of BZs have been administered has provided further support for the involvement of alterations in AMPA receptor properties, particularly in the hippocampus, following BZ withdrawal (Izzo et al, 2001; Van Sickle and Tietz, 2002; Van Sickle et al, 2004).”
BackgroundInfluentialTsuda, M., Suzuki, T., & Misawa, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00052-3 · Cited by 28 · cited 1×
“Several studies have also provided evidence for a role for NMDA receptor antagonists in blocking the behavioral components of BZ tolerance and withdrawal (Steppuhn and Turski, 1993; File and Fernandes, 1994; Koff et al, 1997; Tsuda et al, 1998a, b).”
BackgroundRole of NMDA, Non-NMDA, and GABA Receptors in Signal Propagation in the Amygdala Formation
Wang, C., Wilson, W. A., & Moore, S. D. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.3.1422 · Cited by 28 · cited 1×
“Again in similarity with the hippocampus, there is a close relationship between glutamate and GABA transmission in the amygdala (Wang et al, 2001).”
BackgroundBinding Characteristics of a Potent AMPA Receptor Antagonist [3H]Ro 48‐8587 in Rat Brain
Mutel, V., Trube, G., Klingelschmidt, A., Messer, J., Bleuel, Z., Humbel, U., Clifford, M., Ellis, G. J., & Richards, J. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010418.x · Cited by 26
Brett, R. R., & Pratt, J. A. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15083.x · Cited by 26 · cited 1×
“Despite these brain structures displaying changes in functional activity (Laurie and Pratt, 1989, 1993), they did not exhibit alterations in GABAA receptor binding properties in complementary receptor autoradiography studies (Brett and Pratt, 1995).”
BackgroundSelf-citationSandra, E. E. (1989) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470040111 · Cited by 25
Dunworth, S. J., & Stephens, D. N. (1998) · Psychopharmacology · doi:10.1007/s002130050571 · Cited by 23 · cited 7×
“…(Allison et al, 2005) consistent with a hypothesis that neuroadaptive changes at the level of the AMPA receptor are involved in the differential effects of these treatment regimes on behavioral measures of with- drawal (Ward and Stephens, 1998; Dunworth and Stephens, 1998; Dunworth et al, 2000).”
BackgroundResultInfluentialLaurie, D., & Pratt, J. A. (1989) · Brain Research · doi:10.1016/0006-8993(89)91603-x · Cited by 21 · cited 4×
“Despite these brain structures displaying changes in functional activity (Laurie and Pratt, 1989, 1993), they did not exhibit alterations in GABAA receptor binding properties in complementary receptor autoradiography studies (Brett and Pratt, 1995).”
BackgroundSelf-citationPratt, J. A., Laurie, D., & McCulloch, J. (1988) · Brain Research · doi:10.1016/0006-8993(88)90610-5 · Cited by 21 · cited 1×
“The hippocampal formation has been implicated in anxiety (Gray, 1987; Pratt, 1992; Pratt et al, 1988), kindling, and epileptogenic behavior (eg Mody and Heinemann, 1987; Gale, 1992).”
Self-citationLevels of GABAa receptor subunit mRNA in rat brain following flurazepam treatment
O'Donovan, M. C., Buckland, P. R., & McGuffin, P. (1992) · Journal of Psychopharmacology · doi:10.1177/026988119200600304 · Cited by 20
Dunworth, S. J., Mead, A. N., & Stephens, D. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00036.x · Cited by 19 · cited 2×
“…(Allison et al, 2005) consistent with a hypothesis that neuroadaptive changes at the level of the AMPA receptor are involved in the differential effects of these treatment regimes on behavioral measures of with- drawal (Ward and Stephens, 1998; Dunworth and Stephens, 1998; Dunworth et al, 2000).”
BackgroundAllison, C., Claase, L.-A., & Pratt, J. A. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00015 · Cited by 13 · cited 7×
“…treatment) or repeated withdrawal events (i.p. treatment), based on pharmacokinetic evidence in rats (Friedman et al, 1986; Fernandes et al, 1999; Allison et al, 2002) and behavioral evidence in mice that repeated withdrawal from DZP results in amelioration of the anxiogenic effects of…”
BackgroundMethodResultSelf-citationAllison, C., Pratt, J. A., Ripley, T. L., & Stephens, D. N. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03902.x · Cited by 12 · cited 3×
“This is further supported by recent mouse studies in our laboratories in which there was an increase in AMPA receptor binding in the hippocampus following a single withdrawal from chronic DZP (Allison et al, 2005).”
BackgroundResultSelf-citationFlumazenil induces localised increases in glucose utilization during diazepam withdrawal in rats
Laurie, D., & Pratt, J. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91546-5 · Cited by 9 · cited 2×
“Despite these brain structures displaying changes in functional activity (Laurie and Pratt, 1989, 1993), they did not exhibit alterations in GABAA receptor binding properties in complementary receptor autoradiography studies (Brett and Pratt, 1995).”
BackgroundSelf-citationProgressive Spinal Muscular Atrophies (The International Review of Child Neurology)
Walton, S. J. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90161-4 · Cited by 3
Investigations of regional changes in AMPA receptor characteristics during diazepam withdrawal.
Allison, C. (2002) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Self-citation(2000) · doi:10.1002/1096-9861(20000925)425:3
Research works printed but not linked: 5
- Del Cano GG, Gerrikagoitia I, Martinez-Millan L (2000). Morphology and topographical organisation of the retrospleniocollicular connection: a pathway to relay contextual information from the environment to the superior colliculus. J Comp Neurol 425: 393–408. · doi:10.1002/1096-9861(20000925)425:3<393::aid-cne5>3.0.co;2-g
- Gray JA (1987). The Neuropsychology of Anxiety. An Enquiry in to the Functions of the Septohippocampal System. Oxford Science Publications: New York.
- Stephens DN (1995). A glutamatergic hypothesis of drug dependence. Behav Pharmacol 6: 425–446.
- Wisden W, Morris BJ (1994). In situ hybridisation with synthetic probes. In: Wisden W, Morris BJ (eds). In Situ Hybridisation Protocols for the Brain. Academic Press: London. pp 9–34.
- Zhao TJ, Chiu TH, Rosenberg HC (1994). Reduced expression of GABAA/benzodiazepine receptor γ2 and α5 subunit mRNAs in brain regions of flurazepam treated rats. Mol Pharmacol 45: 657–663.
Cited by
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
“In contrast to those studies, expression of the AMPA receptor subunits was decreased in the amygdala (GluR1 and GluR2) and limbic regions (GluR1; Allison and Pratt, 2006).”
ResultThe Howling Cortex: Seizures and General Anesthetic Drugs
Voss, L. J., Sleigh, J. W., Barnard, J. P. M., & Kirsch, H. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181852595 · Cited by 196
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Even though the AMPA receptor antagonist GYKI 52466 did not affect the development of tolerance to the sedative effects of diazepam [121], changes in AMPA receptor subunits have been reported to be altered after long-term benzodiazepine exposure [130].”
BackgroundPanhelainen, A. E., Möykkynen, T. P., & Korpi, E. R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.89 · Cited by 119
GABAA Receptor α Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment
Vinkers, C. H., van Oorschot, R., Nielsen, E. Ø., Cook, J. M., Hansen, H. H., Groenink, L., Olivier, B., & Mirza, N. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043054 · Cited by 47
Metadata
- Authors
- Allison, C., & Pratt, J. A.
- Affiliations
- University of Strathclyde (GB)
- Corresponding author
- Allison, Claire
- ORCID
- Pratt, Judith A
- Venue
- Neuropsychopharmacology
- Published
- 2005-06-22
- Volume
- 31
- Issue
- 3
- Pages
- 602-619
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2012368714
- Cited by
- 27
- References
- 101
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 2 · 2021: 3 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- diazepam withdrawal, GluR1 subunit, GluR2 subunit, hippocampus, amygdala, agranular insular cortex, striatum, neural adaptation, elevated plus maze
- MeSH terms
- Animals, Anxiety, Autoradiography, Diazepam, Hypnotics and Sedatives, Imidazoles, Injections, Intraperitoneal, Injections, Subcutaneous, Male, Quinazolines, RNA, Messenger, Substance Withdrawal Syndrome, Oligonucleotide Probes, In Situ Hybridization, Receptors, AMPA, Excitatory Amino Acid Antagonists, Rats, Long-Evans, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.